Log In
Saturday 24th March 2018

Drug boosting survival hopes for breast cancer sufferers

5th June 2007
Cancer drug Hercepin, could reduce the number of mastectomies if used alongside chemotherapy before women undergo surgery, a study has shown.  Women who suffer from a certain type of breast cancer, HER-2-positive, who are treated in this way were more likely to see tumours shrink substantially, meaning surgery that would conserve the bresat can be carrid out, according to new stattistics.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Drug boosting survival hopes for breast cancer sufferers
Author: Anne Waller
Article Id: 3044
Date Added: 5th Jun 2007


Birmingham Post

Recent Related Articles

Prescription drug addiction to be reviewed

Obesity can lead to certain cancers

Women unhappy with breast size don't self-examine


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018